Aditya Kohli is the founder of HilleVax. HilleVax has raised $135M in total funding. Latest round: IPO. Backed by Frazier Life Sciences.
Aditya Kohli is a Partner at Frazier Life Sciences, specializing in company creation. He co-founded six companies, including HilleVax (NASDAQ: HLVX) and Phathom Pharmaceuticals (NASDAQ: PHAT), serving as Chief Operating Officer of HilleVax from 2020 to 2024 and Chief Business Officer of Phathom Pharmaceuticals from 2019 to 2021. Prior to Frazier, he was an Engagement Manager at McKinsey & Company.
Full founder directory · Investor directory · Company funding database · Fundraising library